T2S Group advances Morocco stock market debut with $117 million offering

T2S Group Holding, a leading medical technology company, has secured approval from the Moroccan Capital Market Authority, known as AMMC, to proceed with a stock market operation valued at nearly MAD 1.1 billion, or about $117 million. The move marks a major milestone in the company’s Morocco stock market strategy as it seeks new funding and broader investor participation.

The transaction combines a public capital increase with the sale of existing shares. Around MAD 350 million is expected to be raised through newly issued shares offered to investors. An additional MAD 750 million will come from the sale of shares currently held by existing stakeholders.

The operation is designed to strengthen the company’s financial resources while increasing its visibility in capital markets. It also supports T2S Group’s long-term growth plans in Morocco and across Africa.

Founded in 1992, T2S Group has developed into a major player in Morocco’s healthcare technology sector. The company provides medical equipment, technical services, installation, maintenance, and long-term support to hospitals and healthcare facilities.

Its activities cover several specialized segments, including medical imaging systems, oncology equipment, operating room technologies, laboratory diagnostics, nuclear medicine products, hospital digital solutions, and devices used in minimally invasive procedures.

The company’s expansion reflects growing demand for advanced healthcare technologies throughout the patient care process, from diagnosis to treatment and follow-up. By integrating equipment supply with technical support services, T2S Group has established a broad presence within the healthcare ecosystem.

The group works with more than 40 international manufacturers and offers a portfolio exceeding 8,000 medical product references. These partnerships provide access to internationally recognized technologies while supporting the needs of healthcare providers in local markets.

Beyond Morocco, T2S Group has expanded operations into more than 20 African countries. Its regional network is supported by a centralized logistics platform and a workforce of over 400 employees.

Looking ahead, the company plans to reinforce its core business lines and introduce new technologies in high-value medical segments. Management also intends to accelerate growth across African markets and pursue selected acquisition opportunities that complement its existing activities.

The planned market listing is expected to provide additional resources for these objectives. As healthcare demand rises across the region due to demographic changes and evolving medical needs, T2S Group is positioning itself to expand its role in the MedTech sector while strengthening its institutional profile through public market participation.